NASDAQ: CORT
Corcept Therapeutics Inc Stock Ownership - Who owns Corcept Therapeutics?

Insider buying vs selling

Have Corcept Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
James N. WilsonDirector2026-11-132,191$71.80
$157.32kSell
James N. WilsonDirector2026-11-1325$74.28
$1.86kSell
James N. WilsonDirector2026-11-13563$73.42
$41.33kSell
James N. WilsonDirector2026-11-137,221$72.87
$526.17kSell
Daniel N. Swisher Jr.Director2026-11-10400$10.50
$4.20kBuy
Daniel N. Swisher Jr.Director2026-11-101,500$74.07
$111.10kSell
Daniel N. Swisher Jr.Director2026-11-101,100$14.08
$15.49kBuy
Sean MaduckInsider2026-11-0313,159$8.27
$108.82kBuy
Sean MaduckInsider2026-11-034,542$82.68
$375.51kSell
Sean MaduckInsider2026-11-038,617$82.02
$706.77kSell

1 of 21

CORT insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CORT insiders and whales buy or sell their stock.

CORT Shareholders

What type of owners hold Corcept Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Patrick G. Enright40.94%44,802,403$3.04BInsider
Bakker Juliet Tammenoms10.13%11,089,541$751.76MInsider
Longitude Venture Partners LP10.01%10,956,002$742.71MInsider
Alta Biopharma Partners II LP9.12%9,982,720$676.73MInsider
G. Leonard Baker Jr.8.63%9,440,067$639.94MInsider
Tench Coxe6.30%6,890,503$467.11MInsider
Joseph C. Cook Jr.6.18%6,765,805$458.65MInsider
David L. Anderson5.87%6,420,729$435.26MInsider
William H. Younger Jr.5.81%6,353,537$430.71MInsider
Joseph K. Belanoff5.71%6,248,596$423.59MInsider

1 of 3

CORT vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CORT0.04%99.96%Net BuyingNet Selling
AXSM0.08%57.78%Net SellingNet Buying
CYTK0.12%10.92%Net SellingNet Selling
IBRX0.02%7.18%Net BuyingNet Selling
CGON0.10%16.26%Net BuyingNet Buying

Corcept Therapeutics Stock Ownership FAQ

Who owns Corcept Therapeutics?

Corcept Therapeutics (NASDAQ: CORT) is owned by 0.07% institutional shareholders, 177.29% Corcept Therapeutics insiders, and 0.00% retail investors. Patrick G. Enright is the largest individual Corcept Therapeutics shareholder, owning 44.80M shares representing 40.94% of the company. Patrick G. Enright's Corcept Therapeutics shares are currently valued at $2.91B.

If you're new to stock investing, here's how to buy Corcept Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.